Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: Implications for the outcome

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 2, 2000, Pages 106-111

  Ortega, Jorge A ^a   Rowland, Jon ^a,b   Monforte, Hector ^a,b   Malogolowkin, Marcio ^a   Triche, Timothy ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Differentiated rhabdomyoblasts; End of therapy; Rhabdomyosarcoma

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CLINICAL ARTICLE; CYSTOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOSIS RATE; MUSCLE BIOPSY; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIFFERENTIATION; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PELVIC NEOPLASMS; PROSTATIC NEOPLASMS; RHABDOMYOSARCOMA; URINARY BLADDER NEOPLASMS; VAGINAL NEOPLASMS; VINCRISTINE; VULVAR NEOPLASMS;

EID: 0034458293     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200003000-00005     Document Type: Article

References (19)

1. Altamannsberger M, Dirk T, Osborn M. Immunohistochemistry of cytoskeletal filaments in the diagnosis of soft tissue tumors. Semin Diagn Pathol 1986;3: 306-11.
2. Eusebi V, Ceccarelli C, Gorza L, et al. Immunocytochemistry of rhabdomyosarcoma. The use of four different markers. Am J Surg Pathol 1986;10: 293-9.
3. Molenaar WM, Oosterhuis JW, Oosterhuis AM, et al. Mesenchymal and muscle-specific intermediate filaments (Vimentin and Desmin) in relation to differentiation in childhood rhabdomyosarcoma. Hum Pathol 1985;16: 838-43.
4. Stout AP. Tumors of the soft tissues. In: Atlas of Tumor Pathology, Section 11, Fascicle 5. Washington DC, AFIP, 1953.
5. Schmidt D, Reimann O, Treuner J, et al. Cellular differentiation and prognosis in embryonal rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma Study 1981 (CWS 81). Virchow’s Arch [A] 1986;409(2): 183-94.
6. Rivard G, Ortega JA, Hittle R, et al. Intensive chemotherapy as primary treatment for rhabdomyosarcoma of the pelvis. Cancer 1975;36: 1593-7.
7. Ortega JA. A therapeutic approach to childhood pelvic rhabdomyosarcoma without pelvic exenteration. J Pediatr 1979;94: 205-9.
8. Crist W, Gehan EA, Ragab AH, et al. The third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13: 610-30.
9. Ortega JA, Ragab AH, Gehan E, et al. Ifosfamide (I), Actinomycin-D (AD), and vincristine (VCR) for the treatment of childhood rhabdomyosarcoma (RMS): a feasibility and toxicity study. A report for the Intergroup Rhabdomyosarcoma Study (IRS-IV) [abstract]. Proc Am Soc Clin Oncol 1991;10: 314.
10. Oberlin O, Rodary C, Torbey PH. Effectiveness of the SIOP conservative approach for the treatment of localized rhabdomyosarcoma (RMS). XXVI Meeting International Society Pediatric Oncology [abstract]. Med Pediatr Oncol 1994;23: 171.
11. Maurer HM. The Intergroup Rhabdomyosarcoma Study. Objectives and clinical staging classification. J Pediatr Surg 1975;10: 977-8.
12. Maurer HM, Gehan FA, Beltagady M, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer 1993;71: 1904-22.
13. Hays DN, Raney RB, Crist WM, et al. Improved survival and bladder preservation among patients with bladder-prostate primary tumors in Intergroup Rhabdomyosarcoma Study II (IRS) [abstract]. Proc Am Soc Clin Oncol 1991;10: 318.
14. Heyn R, Newton WA, Raney B, et al. Preservation of the bladder in patients with rhabdomyosarcoma. J Clin Oncol 1997;15: 69-75.
15. Molenaar WM, Oosterhuis JW, Kamps WA. Cytologic differentiation in childhood polychemotherapy. Hum Pathol 1984;15: 973.
16. Atra A, Ward HC, Aitken K, et al. Conservative surgery in multimodal therapy for pelvic rhabdomyosarcoma in children. Br J Cancer 1994;70(5): 1004-8.
17. Hawkins HK, Camacho-Velasquez JV. Rhabdomyosarcoma in children. Correlation of form and prognosis in one institution’s experience. Am J Surg Pathol 1987;11(7): 531-42.
18. Newton WA Jr., Hamoudi A, Webber B, et al. Pathology of rhabdomyosarcoma and related tumors: experience of the Intergroup Rhabdomyosarcoma Studies. In Maurer HM, Ruymann FB, Pochedly C, eds. Rhabdomyosarcoma and Related Tumors in Children and Adolescents. Boca Raton, FL, CRC Press, Inc., 1991: 19-48.
19. d’Amore ES, Tollot M, Stracca-Pausa J, et al. Therapy-associated differentiation in rhabdomyosarcomas. Mod Pathol 1994;7: 69-75.